Lord, Abbett & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$31.6M Buy
2023
Q1
$7.46M Buy
2016
Q2
Sell
2016
Q1
$1.65M Sell
2015
Q4
$20.8M Buy
2015
Q3
$5.94M Sell
2015
Q2
$6.44M Buy
2014
Q4
Sell
2014
Q3
$5.38M Buy
2014
Q2
$6.82M Buy
2014
Q1
$3.9M Buy